Abstract
Biosensors employing single-walled carbon nanotube field-effect transistors (SWCNT FETs) offer ultimate sensitivity. However, besides the sensitivity, a high selectivity is critically important to distinguish the true signal from interference signals in a non-controlled environment. This work presents the first demonstration of the successful integration of a novel peptide aptamer with a liquid-gated SWCNT FET to achieve highly sensitive and specific detection of Cathepsin E (CatE), a useful prognostic biomarker for cancer diagnosis. Novel peptide aptamers that specifically recognize CatE are engineered by systemic in vitro evolution. The SWCNTs were firstly grown using the thermal chemical vapor deposition (CVD) method and then were employed as a channel to fabricate a SWCNT FET device. Next, the SWCNTs were functionalized by noncovalent immobilization of the peptide aptamer using 1-pyrenebutanoic acid succinimidyl ester (PBASE) linker. The resulting FET sensors exhibited a high selectivity (no response to bovine serum albumin and cathepsin K) and label-free detection of CatE at unprecedentedly low concentrations in both phosphate-buffered saline (2.3 pM) and human serum (0.23 nM). Our results highlight the use of peptide aptamer-modified SWCNT FET sensors as a promising platform for near-patient testing and point-of-care testing applications.
Highlights
IntroductionOur device exhibited good selectivity (no response for bovine serum albumin (BSA) and cathepsin K (CatK)) and a low detection limit
The emergence of biosensor devices that convert a biological response into an electrical signal can address the rapidly increasing need in the point-of-care testing (POCT) market and achieve wide-scale application
This work details the successful fabrication and demonstration of a liquid-gated SWCNT field-effect transistors (FETs) sensor modified with Cathepsin E (CatE)-binding peptide aptamers as an attractive platform for POCT application for the detection of unreached disease biomarkers such as serum CatE, which has recently been highlighted as a novel prognostic biomarker for cancer because the reduction of serum level of CatE has been associated with poor prognosis in breast cancer patients[20]
Summary
Our device exhibited good selectivity (no response for bovine serum albumin (BSA) and cathepsin K (CatK)) and a low detection limit The sensitivity of this device could improve the limit of detection of CatE in human serum by at least three orders of magnitude compared with a conventional ELISA-based system using a similar peptide aptamer[19]. This work details the successful fabrication and demonstration of a liquid-gated SWCNT FET sensor modified with CatE-binding peptide aptamers as an attractive platform for POCT application for the detection of unreached disease biomarkers such as serum CatE, which has recently been highlighted as a novel prognostic biomarker for cancer because the reduction of serum level of CatE has been associated with poor prognosis in breast cancer patients[20]. To the best of our knowledge, this work represents the first report of an FET-type sensor utilizing peptide aptamer-modified SWCNTs; this novel sensor can lead to the development of a portable and affordable sensing system for high-performance near-patient testing
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.